These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
672 related articles for article (PubMed ID: 12912953)
1. Epigenetic down-regulation of death-associated protein kinase in lung cancers. Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic inactivation of laminin-5-encoding genes in lung cancers. Sathyanarayana UG; Toyooka S; Padar A; Takahashi T; Brambilla E; Minna JD; Gazdar AF Clin Cancer Res; 2003 Jul; 9(7):2665-72. PubMed ID: 12855645 [TBL] [Abstract][Full Text] [Related]
3. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer. Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112 [TBL] [Abstract][Full Text] [Related]
4. Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma. Kong WJ; Zhang S; Guo CK; Wang YJ; Chen X; Zhang SL; Zhang D; Liu Z; Kong W Anticancer Drugs; 2006 Mar; 17(3):251-9. PubMed ID: 16520653 [TBL] [Abstract][Full Text] [Related]
5. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832 [TBL] [Abstract][Full Text] [Related]
7. Reduced expression of death-associated protein kinase in human uterine and ovarian carcinoma cells. Bai T; Tanaka T; Yukawa K; Maeda M; Umesaki N Oncol Rep; 2004 Mar; 11(3):661-5. PubMed ID: 14767518 [TBL] [Abstract][Full Text] [Related]
8. Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis. Takai D; Yagi Y; Wakazono K; Ohishi N; Morita Y; Sugimura T; Ushijima T Oncogene; 2001 Nov; 20(51):7505-13. PubMed ID: 11709722 [TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells. Tang X; Wu W; Sun SY; Wistuba II; Hong WK; Mao L Mol Cancer Res; 2004 Dec; 2(12):685-91. PubMed ID: 15634757 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of death-associated protein kinase expression in primary gastric cancers from Chinese patients. Ye M; Li D; Zhou F; Guo Q; Xia B Eur J Cancer Prev; 2012 May; 21(3):241-6. PubMed ID: 21979297 [TBL] [Abstract][Full Text] [Related]
11. Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures. Toyooka S; Fukuyama Y; Wistuba II; Tockman MS; Minna JD; Gazdar AF Clin Cancer Res; 2002 Jul; 8(7):2292-7. PubMed ID: 12114433 [TBL] [Abstract][Full Text] [Related]
12. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer. Chen W; Gao N; Shen Y; Cen JN J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341 [TBL] [Abstract][Full Text] [Related]
13. Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer. Obata T; Toyota M; Satoh A; Sasaki Y; Ogi K; Akino K; Suzuki H; Murai M; Kikuchi T; Mita H; Itoh F; Issa JP; Tokino T; Imai K Clin Cancer Res; 2003 Dec; 9(17):6410-8. PubMed ID: 14695142 [TBL] [Abstract][Full Text] [Related]
14. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray. Wang Y; Zhang D; Zheng W; Luo J; Bai Y; Lu Z Cancer; 2008 Mar; 112(6):1325-36. PubMed ID: 18286531 [TBL] [Abstract][Full Text] [Related]
15. Expression of death-associated protein kinase during tumour progression of human renal cell carcinomas: hypermethylation-independent mechanisms of inactivation. Wethkamp N; Ramp U; Geddert H; Schulz WA; Florl AR; Suschek CV; Hassan M; Gabbert HE; Mahotka C Eur J Cancer; 2006 Jan; 42(2):264-74. PubMed ID: 16386893 [TBL] [Abstract][Full Text] [Related]
16. DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value. Vallböhmer D; Brabender J; Yang D; Schneider PM; Metzger R; Danenberg KD; Hölscher AH; Danenberg PV Clin Lung Cancer; 2006 Jul; 8(1):39-44. PubMed ID: 16870044 [TBL] [Abstract][Full Text] [Related]
17. 5-Aza-CdR can reverse gefitinib resistance caused by DAPK gene promoter methylation in lung adenocarcinoma cells. Yang B; Yang ZG; Gao B; Shao GG; Li GH Int J Clin Exp Pathol; 2015; 8(10):12961-6. PubMed ID: 26722491 [TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023 [TBL] [Abstract][Full Text] [Related]
19. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells. Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657 [TBL] [Abstract][Full Text] [Related]
20. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs. Deng G; Kakar S; Okudiara K; Choi E; Sleisenger MH; Kim YS Clin Cancer Res; 2009 Mar; 15(5):1519-26. PubMed ID: 19223499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]